Sirtuins' control of autophagy and mitophagy in cancer
M Aventaggiato, E Vernucci, F Barreca… - Pharmacology & …, 2021 - Elsevier
Mammalian cells use a specialized and complex machinery for the removal of altered
proteins or dysfunctional organelles. Such machinery is part of a mechanism called …
proteins or dysfunctional organelles. Such machinery is part of a mechanism called …
Sirtuins at the crossroads of stemness, aging, and cancer
C O'Callaghan, A Vassilopoulos - Aging cell, 2017 - Wiley Online Library
Sirtuins are stress‐responsive proteins that direct various post‐translational modifications
(PTM s) and as a result, are considered to be master regulators of several cellular …
(PTM s) and as a result, are considered to be master regulators of several cellular …
Dual tumor suppressor and tumor promoter action of sirtuins in determining malignant phenotype
V Carafa, L Altucci, A Nebbioso - Frontiers in pharmacology, 2019 - frontiersin.org
Sirtuins (SIRTs), class III histone deacetylases, are differentially expressed in several human
cancers, where they display both oncogenic and tumor-suppressive properties depending …
cancers, where they display both oncogenic and tumor-suppressive properties depending …
[HTML][HTML] SIRT1 and SIRT6: The role in aging-related diseases
Y You, W Liang - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2023 - Elsevier
Aging is characterized by progressive functional deterioration with increased risk of
mortality. It is a complex biological process driven by a multitude of intertwined mechanisms …
mortality. It is a complex biological process driven by a multitude of intertwined mechanisms …
[HTML][HTML] SIRT6 in aging, metabolism, inflammation and cardiovascular diseases
Z Guo, P Li, J Ge, H Li - Aging and disease, 2022 - ncbi.nlm.nih.gov
As an important NAD+-dependent enzyme, SIRT6 has received significant attention since its
discovery. In view of observations that SIRT6-deficient animals exhibit genomic instability …
discovery. In view of observations that SIRT6-deficient animals exhibit genomic instability …
Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target
XL Ma, YF Sun, BL Wang, MN Shen, Y Zhou, JW Chen… - BMC cancer, 2019 - Springer
Backgrounds The role of sphere-forming culture in enriching subpopulations with stem-cell
properties in hepatocellular carcinoma (HCC) is unclear. The present study investigates its …
properties in hepatocellular carcinoma (HCC) is unclear. The present study investigates its …
The roles of sirtuins family in cell metabolism during tumor development
S Zhu, Z Dong, X Ke, J Hou, E Zhao, K Zhang… - Seminars in cancer …, 2019 - Elsevier
Altering energy metabolism to meet the uncontrolled proliferation and metastasis has
emerged as one of the most significant hallmarks in tumors. However, the detailed molecular …
emerged as one of the most significant hallmarks in tumors. However, the detailed molecular …
Nicotine promotes neuron survival and partially protects from Parkinson's disease by suppressing SIRT6
JW Nicholatos, AB Francisco, CA Bender, T Yeh… - Acta neuropathologica …, 2018 - Springer
Parkinson's disease is characterized by progressive death of dopaminergic neurons,
leading to motor and cognitive dysfunction. Epidemiological studies consistently show that …
leading to motor and cognitive dysfunction. Epidemiological studies consistently show that …
Pharmacological activation of SIRT6 triggers lethal autophagy in human cancer cells
S Iachettini, D Trisciuoglio, D Rotili, A Lucidi… - Cell death & …, 2018 - nature.com
Abstract Sirtuin 6 (SIRT6) is a member of the NAD+-dependent class III deacetylase sirtuin
family, which plays a key role in cancer by controlling transcription, genome stability …
family, which plays a key role in cancer by controlling transcription, genome stability …
[HTML][HTML] Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing …
C O'Brien, T Ling, JM Berman, R Culp-Hill… - …, 2023 - ncbi.nlm.nih.gov
Outcomes for patients with acute myeloid leukemia (AML) remain poor due to the inability of
current therapeutic regimens to fully eradicate disease-initiating leukemia stem cells (LSC) …
current therapeutic regimens to fully eradicate disease-initiating leukemia stem cells (LSC) …